1-3 of 3
David J. Margolis
Close
Sort by
Journal Articles

Real World Outcomes of Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation and Receive Commercially-Available Salvage Therapy

Emily C. Ayers, MD, David J Margolis, MD, Phyllis A. Gimotty, PhD, Daniel J. Landsburg, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2893.
https://doi.org/10.1182/blood-2019-128815
Published: 2019
Journal Articles

Next Generation Sequencing (NGS) Identifies an Association Between NPM1 Mutation and Leukemia Cutis

Marlise R. Luskin, MD, Campbell L. Stewart, MD, Jennifer JD Morrissette, PhD, David Lieberman, MS, CGC, David J. Margolis, MD, Alexander E. Perl, MD, Misha A. Rosenbach, MD
Journal: Blood
Blood (2014) 124 (21): 2341.
https://doi.org/10.1182/blood.V124.21.2341.2341
Published: 2014
Journal Articles

Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia

Courtney D. DiNardo, Kathleen J. Propert, Alison W. Loren, Elisabeth Paietta, Zhuoxin Sun, Ross L. Levine, Kimberly S. Straley, Katharine Yen, Jay P. Patel, Samuel Agresta, Omar Abdel-Wahab, Alexander E. Perl, Mark R. Litzow, Jacob M. Rowe, Hillard M. Lazarus, Hugo F. Fernandez, David J. Margolis, Martin S. Tallman, Selina M. Luger, Martin Carroll
Journal: Blood
Blood (2013) 121 (24): 4917–4924.
https://doi.org/10.1182/blood-2013-03-493197
Published: 2013
Includes: Supplemental data